Vanguard Group’s DMK Pharmaceuticals Corporation Common Stock DMK Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | – | Sell |
|
|||||
2023
Q4 | $23.8K | Buy |
|
|||||
2023
Q3 | $20.7K | Sell |
|
|||||
2023
Q2 | $74.5K | Sell |
|
|||||
2023
Q1 | $751K | Hold |
|
|||||
2022
Q4 | $1.1M | Buy |
|
|||||
2022
Q3 | $1.29M | Hold |
|
|||||
2022
Q2 | $3.25M | Hold |
|
|||||
2022
Q1 | $3.7M | Sell |
|
|||||
2021
Q4 | $3.94M | Buy |
|
|||||
2021
Q3 | $6.32M | Buy |
|
|||||
2021
Q2 | $6.95M | Buy |
|
|||||
2021
Q1 | $5.39M | Buy |
|
|||||
2020
Q4 | $1M | Buy |
|
|||||
2020
Q3 | $1.53M | Buy |
|
|||||
2020
Q2 | $1.02M | Buy |
|
|||||
2020
Q1 | $673K | Hold |
|
|||||
2019
Q4 | $1.32M | Sell |
|
|||||
2019
Q3 | $1.36M | Buy |
|
|||||
2019
Q2 | $2.33M | Buy |
|
|||||
2019
Q1 | $3.62M | Buy |
|
|||||
2018
Q4 | $2.39M | Sell |
|
|||||
2018
Q3 | $5.73M | Buy |
|
|||||
2018
Q2 | $4.13M | Buy |
|
|||||
2018
Q1 | $4.48M | Buy |
|
|||||
2017
Q4 | $5.45M | Buy |
|
|||||
2017
Q3 | $5.91M | Buy |
|
|||||
2017
Q2 | $4.9M | Buy |
|
|||||
2017
Q1 | $3.28M | Buy |
|
|||||
2016
Q4 | $2.15M | Buy |
|
|||||
2016
Q3 | $1.88M | Buy |
|
|||||
2016
Q2 | $940K | Buy |
|
|||||
2016
Q1 | $1.69M | Buy |
|
|||||
2015
Q4 | $1.42M | Buy |
|
|||||
2015
Q3 | $1.01M | Buy |
|
|||||
2015
Q2 | $1.06M | Buy |
|
|||||
2015
Q1 | $931K | Buy |
|
|||||
2014
Q4 | $370K | Buy |
|
|||||
2014
Q3 | $102K | Buy |
|